A pivotal announcement from the U.S. Food and Drug Administration (FDA) has cast a spotlight on the safety of certain medical imaging devices produced by Philips, a renowned Dutch manufacturer of medical equipment. This alert, issued on December 20, elevates the recall of specific Philips imaging devices to the highest level of urgency, indicating a risk of severe injury or even death from their use.
The recall specifically targets the Panorama 1.0T HFO models, with the FDA citing a potential explosion hazard during a procedure known as “quenching.” This process, involving the rapid evaporation and release of helium gas, can lead to hazardous pressure buildup if there’s an obstruction in the venting system. The recall encompasses about 150 units in the U.S., with Philips having initiated this process on November 30.
Philips’ shares in the U.S. market experienced a 1% decline following this announcement. The devices in question are integral in medical diagnostics, allowing for internal imaging crucial for disease detection and monitoring treatment progress.
Philips has been actively addressing the issue, with inspections already conducted on approximately 80% of the operational systems in the United States. The company aims to complete all inspections promptly. Philips ceased the production and sale of this line of imaging devices in 2014, although they were distributed from January 1, 2001, to October 1, 2016.
FDA’s Safety Assessment
The FDA’s evaluation highlights significant health risks associated with the malfunction of these devices, including chemical exposure, oxygen deprivation, and potential tissue damage. Despite one reported incident of explosion in over two decades and no recorded injuries or fatalities, the recall underscores the importance of stringent safety measures.
This recall is part of a larger pattern for Philips, following a major global recall in 2021 involving millions of respirators for sleep apnea treatment. The company is actively managing the repercussions of these recalls to ensure patient safety.
Legal Recourse for Affected Individuals
The malfunction of Philips’ medical imaging devices presents not only a health risk but also potential legal ramifications. Victims who have suffered due to these devices can face a range of consequences, from physical harm to psychological trauma. In such cases, filing a product liability lawsuit may be an appropriate course of action. This type of lawsuit seeks to hold the manufacturer responsible for injuries caused by defective products.
The legal journey in a product liability case involves several stages, including the collection of evidence, filing a lawsuit, the discovery phase, and possibly a trial. Each phase demands careful legal strategy and knowledge of the complex laws governing product liability.
Given the intricacies of such cases, securing the services of an experienced attorney is crucial. A lawyer specializing in product liability can guide victims through the legal process, represent their interests, and negotiate for appropriate compensation.
Victims in product liability cases may be eligible for compensation covering medical expenses, lost income, pain and suffering, and in some cases, punitive damages. The extent of compensation depends on the severity of the injury and the specific circumstances.
CONTACT PARKER WAICHMAN LLP FOR A FREE CASE REVIEW
If you have been affected by the Philips medical imaging device recall, it is important to explore your legal options. Parker Waichman LLP, a nationally recognized law firm specializing in product injury cases, offers their expertise to guide you through this challenging time. Contact them for a free consultation at 1-800-YOUR-LAWYER (1-800-968-7529). With their support, you can pursue the compensation you deserve and hold responsible parties accountable for the harm caused by defective products.
Regardless of your location or where your injury occurred, our nationwide personal injury law firm is ready to assist you.
.svg){kind=small}
.avif)
.avif)